Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: sailor who wrote (3507)	12/12/1997 12:27:00 PM
From: LoLoLoLita	Read Replies (1) \| Respond to of 23519

Class-action lawsuit against Dr. Greco. Let's put him out of business!

To: sailor who wrote (3507)	12/12/1997 12:30:00 PM
From: Colby	Respond to of 23519

I bought some more yesterday @ just under 13. The Co. said it had $97 MM as of 9/31/97. With 33.5MM shares outstanding and no debt (I think that is correct) we are talking about a $435 MM market cap. You can buy the co. for $340MM (435-97 cash). Seems pretty cheap to me considering they had over $100 MM of revenue this year. For the record, they did say demand had tapered off and, in fact, may be starting to decline. We are reaching a point where the D curve and the S curve intersect. They were pleased the D has stayed as consistent as it has for as long as it has considering they have not put "$1 into stimulating demand." My personal opinion: In a couple of months this is going to be one of those 20/20 hindsight buys. I realize there are some challenges to be met, of which some may be more difficult than the company anticipates, but even so, This company is way too cheap. A little pacience goes a long way, Colby